Clinical Trial Update: Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) [Phase 4]

View source ↗

Summary

Phase 4 ALTER study evaluating the use of adefovir and lamivudine for patients with entecavir-resistant chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• Lamivudine (lamivudine)

Snippet

Sponsor: Korea University | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED